Antifibrotic Therapy

Antifibrotic therapy is a research domain and therapeutic strategy focused on understanding, developing, and evaluating interventions aimed at inhibiting or reversing pathological tissue fibrosis. It encompasses the investigation of pharmacological agents and other modalities to slow disease progression, mitigate organ dysfunction, and improve clinical outcomes in a range of fibrotic diseases.

1.5K

Publications

93.1K

Citations

8.7K

Authors

Institutions

Publications per year

2017–2026

492

Variants

Antifibrotic Therapies

Parents

Pulmonary Fibrosis

Publications

1.5K

Research papers and scholarly works on Antifibrotic Therapy.

	Year	Citations
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Paul W. Noble, Carlo Albera, Williamson Z. Bradford, · The Lancet Antifibrotic TherapyIdiopathic Pulmonary FibrosisPharmacology	2011	2.1K
Nephrogenic Systemic Fibrosis Peter Marckmann, Lone Skov, Kristian Rossen, · Journal of the American Society of Nephrology GlomerulonephritisAntifibrotic TherapyFibrosis	2006	1.4K
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Julie A. Bjoraker, Jay H. Ryu, Mark Edwin, · American Journal of Respiratory and Critical Care Medicine FibrosisAntifibrotic TherapyPulmonary Pathology	1998	1K
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, · American Journal of Respiratory and Critical Care Medicine Acute Lung InjuryFatal DisorderAntifibrotic Therapy	2005	944
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials Peter M.A. Calverley, Klaus F. Rabe, Udo-Michael Goehring, · The Lancet Antifibrotic TherapyPulmonary CareClinical Trials	2009	808

Rows per page

1–5 of 1.5K

Authors

8.7K

Leading researchers in Antifibrotic Therapy. Counts cover only their work on this concept, not their overall record.

	Publications	Citations	H-Index
GR Ganesh Raghu University of Washington	19	2.9K	18
HR Harold R. Collard University of California, San Francisco	14	1.6K	14
LR Luca Richeldi Università Cattolica del Sacro Cuore	15	1.7K	14
AA Arata Azuma Nippon Medical School	15	1.8K	14
SV Srđan Verstovšek The University of Texas MD Anderson Cancer Center	14	686	13

Rows per page

1–5 of 8.7K

Institutions

Leading universities and research organizations in Antifibrotic Therapy. Counts cover only their work on this concept, not their overall record.

	Publications	Citations	H-Index
University of Michigan Ann Arbor, United States	91	18.9K	25
University of California, San Francisco San Francisco, United States	54	6.6K	21
Mayo Clinic in Arizona Scottsdale, United States	63	10K	20
Mayo Clinic Rochester, United States	70	13.5K	20
Inserm Paris, France	91	6K	19

Rows per page

1–5 of 2K

Venues

Leading journals and conferences in Antifibrotic Therapy. Counts cover only their publications on this concept, not their overall record.

	Publications	Citations	H-Index
CHEST Journal	65	5.6K	39
PubMed	99	3K	31
European Respiratory Journal	32	4.1K	28
Respiratory Medicine	31	2.1K	26
American Journal of Physiology-Lung Cellular and Molecular Physiology	22	2.3K	21

Rows per page

1–5